J Korean Pediatr Soc.  1981 Jun;24(6):535-548.

Clinical Observation in Children with Relapsing Minimal Change Nephrotic Syndrome

Affiliations
  • 1Department of Pediatrics, College of Medicine, Seoul National University, Korea.

Abstract

The clinical findings and follow-up data of 37 children with relapsing minimal change nephrotic syndrome were analyzed retrospectively. Among total 37 cases, 31 were male, and 6 were female. Male to female ratio was 5.2:1. All cases were admitted to the Pediatric Ward of Seoul National University Hospital more than one time, and percutaneous kidney needle biopsy which was performed during admission revealed minimal change lesion.(Kidney biopsy was done in cases with unfavorable response to initial conventional steroid therapy and/or with rather frequent relapses.) Mean age at onset was 6 5/12 years, and mean period of follow-up, 3 8/12 years. All of the patients were divided into "Initial Responder"(36 cases, 97.3%) and "Initial Nonresponder"1 case, 2.7%) according to response to steroid therapy and mode of relapse. And, the former group was subdivided into "No Relapser"(1 case, 2.7%, in this case, though no relapse was happened, persistent residual proteinuria after initial steroid therapy led to renal biopsy), "Infrequent Relapser"(18 cases, 48.6%), "Frequent Relapser"(13 cases, 35.1%), and "Subsequent Nonresponder"(4 cases, 10.8%), and the latter group, into "Late Responder"(no case) and "Continuing Nonresponder"(1case, 2.7%). In all cases, as initial symptoms, preceding URI history was detected in 32.4%, and hypertension, hematuria, and azotemia were noted in 13.5%, 10.8%, and 13.5%, respectively. Past medical history of allergy and increased serum IgE level which were suggestive of the parts of evidences for immunopathogenesis of minimal change nephrotic syndrome were found in 29.7% and 35.3%, respectively. Measuring serum levels of other immunoglobulins, IgG had a tendency of decrease, IgM, increase, IgA, variable, and IgD, normal. Among precipitating factors of relapses, URI was found most frequently(15.9%), and in 76.5% of episodes, no precipitating factor was found. Several different findings between in "Infrequent Relapser"(and in "Frequent Relapser"were observed as follows. As for age at onset, in "Infrequent Relapser" the distribution of age was diffusely scattered between 2 to 13 years, while in "Frequent Relapser" its distribution showed a decreasing tendency after initial peak incidence at 3~4 years of age. In "Frequent Relapser"(first relapse was occurred within 3 months after onset in 84.6% of cases, and within 6 months, in all, And in "Infrequent Relapser" first relapse was happened within 3 months after onset in 27.8%, within 6 months in 55.6%, and within 12 months in 94.4% of cases. In most patients of both patient groups, diuresis was initiated within 1 week after the beginning of initial steroid therapy, and loss of proteinuria was achieved within 2 weeks, which were sonewhat faster in "Infrequent Relapser"and 8 cases of "Frequent Relapser" who were followed up more than 3 years, about a half of "Infrequent Relapser" and about three fourths of "Frequent Relapser" were in active disease process with relapse(s) in the third year of follow-up. In 1 case of "Frequent Relapser" and 1 case of "Subsequent Nonresponder", cytoxan therapy was tried with good response.In most cases, several side effects due to long-term steroid therapy were discovered, but all were mild and reversible except 1 case of cataract. Through total period of follow-up in all cases, mortality was absent.


MeSH Terms

Azotemia
Biopsy
Biopsy, Needle
Cataract
Child*
Cyclophosphamide
Diuresis
Female
Follow-Up Studies
Hematuria
Humans
Hypersensitivity
Hypertension
Immunoglobulin A
Immunoglobulin D
Immunoglobulin E
Immunoglobulin G
Immunoglobulin M
Immunoglobulins
Incidence
Kidney
Male
Mortality
Nephrosis, Lipoid*
Precipitating Factors
Proteinuria
Recurrence
Retrospective Studies
Seoul
Cyclophosphamide
Immunoglobulin A
Immunoglobulin D
Immunoglobulin E
Immunoglobulin G
Immunoglobulin M
Immunoglobulins
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr